GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Cash, Cash Equivalents, Marketable Securities

Halberd (Halberd) Cash, Cash Equivalents, Marketable Securities : $0.01 Mil (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Cash, Cash Equivalents, Marketable Securities?

Halberd's quarterly cash, cash equivalents, marketable securities increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.01 Mil) but then stayed the same from Jul. 2022 ($0.01 Mil) to Jul. 2023 ($0.01 Mil).

Halberd's annual cash, cash equivalents, marketable securities increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.01 Mil) but then declined from Jul. 2022 ($0.01 Mil) to Jul. 2023 ($0.01 Mil).


Halberd Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Halberd's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Cash, Cash Equivalents, Marketable Securities Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Cash, Cash Equivalents, Marketable Securities
- 0.01 0.01

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Cash, Cash Equivalents, Marketable Securities - 0.01 0.01

Halberd Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Halberd  (OTCPK:HALB) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Halberd Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Halberd's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236